Gerald Clarke | 08/08/2013
As part of our Future Pharma series, Pharma IQ is examining the promise held by synthetic biology. Our editor spoke to Professor Paul Freemont Chair in Protein Crystallography and Co-Founder and Co-Director of the EPSRC Centre for Synthetic Biology and Innovation at Imperial College London. Professor Freemont Describes the current technical challenges which this exciting field is seeking to overcome, some of the most exciting projects and how synthetic biology will change the pharma industry....
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma & Health 2024
September 10 - 12, 2024
Düsseldorf, Germany
Register Now |
View Agenda |
Learn More
Temperature Control and Logistics North America Summit
September 10 - 12, 2024
Falls Church, VA
Register Now |
View Agenda |
Learn More